Import Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale to India
Import intelligence and supplier data for medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale — powered by UN Comtrade data
28
Supplying Countries (2024)
$219.1M
India’s Import Value
9
Suppliers > $1M
Product Details
Product Name
Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale
HS Code
Chapter
Section
VI — Chemical Products
Industry
Chemicals
Trade Data (HS 4-digit)
3003
About Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale Imports to India
India imports medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale (HS Code 3003) from multiple countries worldwide. This page shows the top supplying countries, import values, and year-over-year trends based on UN Comtrade data.
Import Trend by Year
Top Countries Supplying Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale to India
Based on 2024 import data (HS 3003)
| # | Country | Import Value (USD) | Share |
|---|---|---|---|
| 1 | 🇨🇳 China | $77.6M | 0% |
| 2 | 🇨🇦 Canada | $41.1M | 0% |
| 3 | 🇩🇪 Germany | $40.9M | 0% |
| 4 | 🇳🇱 Netherlands | $27.4M | 0% |
| 5 | 🇳🇵 Nepal | $21.7M | 0% |
| 6 | 🇮🇳 India | $2.7M | 0% |
| 7 | 🇲🇽 Mexico | $1.9M | 0% |
| 8 | 🇫🇷 France | $1.5M | 0% |
| 9 | 🇦🇹 Austria | $1.3M | 0% |
| 10 | 🇰🇷 South Korea | $927K | 0% |
| 11 | 🇨🇭 Switzerland | $771K | 0% |
| 12 | 🇺🇸 United States | $344K | 0% |
| 13 | 🇧🇪 Belgium | $262K | 0% |
| 14 | 🇮🇪 Ireland | $237K | 0% |
| 15 | 🇬🇧 United Kingdom | $145K | 0% |
| 16 | 🇹🇭 Thailand | $129K | 0% |
| 17 | 🇮🇹 Italy | $80K | 0% |
| 18 | 🇧🇷 Brazil | $40K | 0% |
| 19 | 🇫🇮 Finland | $40K | 0% |
| 20 | 🇷🇴 Romania | $16K | 0% |
Related Products in Chemicals
Glands and Other Organs for Organo- Therapeutic Uses, Dried,whether or not Powdered
Glands and Other Organs, Dried, Whether or not Powdered
Extracts of Glands or Other Organs or of Their Secretions
Other
Human Blood
Antisera and Other Blood Fractions and Modified Immunological Products, Whether or not Obtained by M
Vaccines for Human Medicine
Other
Other
Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Mixed or Unmixed Products for Therapeutic or Prophylactic Uses, Put Up in Measured Doses (including Those in the Form of Transdermal Administration Systems) or in Forms or Packings
Containing Penicillins or Derivatives Thereof, with a Penicillanic Acid Structure, or Streptomycins
Containing Other Antibiotics
Explore India's Import Market for Medicaments (excluding Goods of Heading 3002, 3005 or 3006) Consisting of Two or More Constituents Which Have Been Mixed Together for Therapeutic or Prophylactic Uses, not Put Up in Measured Doses or in Forms or Packings for Retail Sale
Get detailed market intelligence, supplier analysis, and trade opportunities.